BEFUNGIN [Chaga Mushroom Tincture]

Active ingredients

Cinder conk extract (Fungi betulini extract) + Cobalt chloride

Contents and packaging

A liquid obtained from the birch tree Chaga mushroom. 100 g of liquid contain 0.175 g of cobalt chloride or 0.2 g of cobalt sulphate; bottle 100 ml.

Pharmacological effect

Pharmacological effect of Befungin include analgesic, tonic and stimulating; in particular, it stimulates the gastrointestinal tract. The preparation stabilizes metabolism.

Pharmacodynamic properties

The mixture’s properties result from its content - biologically active substances such as polysaccharides, humic-like chagic acid, organic acids, trace substances, including manganese and cobalt, hormonal, etc. They are involved in the regulation of tissue metabolism. Befungin suppresses the development of tumour cells, as it influences free radical processes.

Indications

Gastrointestinal diseases (chronic gastritis, dyskinesia of the gastrointestinal tract with symptoms of atony and gastric ulcer) as well as psoriasis and oncogenesis (improvement of the general condition of the patient).

Contradictions

Hypersensitivity

Side effects

Allergic response

Application and dosage

Per os, 30 minutes before meal. Shake well before opening, dilute 3 teaspoons of the mixture in 150 ml of warm boiled water. Take 1 tablespoon 3 times a day for 3-5 months. If necessary, treatment courses can be repeated with intervals of 7-10 days in-between.

Storage conditions

Store in a cool dark place (8-15 C)

Keep out of the reach of children

Shelf life

3 years

Befungin is a restorative and regenerative medicine based on Chaga mushroom. This supplement stimulates metabolism, restores hematogenesis and strengthens immune system after long-term illnesses. Befungin contains the extract of a cinder conk (Chaga mushroom which grows on birch trees) and 1.5% cobalt sulphate or 1% cobalt chloride. The Chaga mushroom is believed to have been discovered and used in China in the 3rd century BC, later being adopted by Japan and then Korea. In the 19th century, it finally came to Russia.

Indications

Befungin can be used as a symptomatic treatment in several gastrointestinal diseases (i.e. chronic gastritis with increased gastric acid secretion, stomach ulcer or violation and tone reduction of gastric motility). Befungin is widely used in oncological diseases. The preparation can be used as a prophylactic treatment in several systemic diseases (i.e. systemic lupus erythematosis and psoriasis).

Befungin stimulates metabolism and promotes healing of gastric or duodenal ulcers. It can be used in chronic gastritis and dyskinesia of the gastrointestinal tract with symptoms of atony. Chaga mushroom-based preparations are biogenic stimulants that strengthen immune system, improve the body cellular defence, stimulate the central nervous system and improve metabolism.

  1. Babitskaia et al (2000) Melanin complex of the fungus Inonotus obliquus https://www.ncbi.nlm.nih.gov/pubmed/10994193
  2. Park et al (2004) Chaga mushroom extract inhibits oxidative DNA damage in human lymphocytes as assessed by comet assay https://www.ncbi.nlm.nih.gov/pubmed/15630179
  3. Ciu et al (2005) Antioxidant effect of Inonotus obliquus https://www.ncbi.nlm.nih.gov/pubmed/15588653
  4. Nakajima et al  (2007) Antioxidant small phenolic ingredients in Inonotus obliquus (persoon) Pilat (Chaga) https://www.ncbi.nlm.nih.gov/pubmed/17666849
  5. Joo et al (2010) Extract of Chaga mushroom (Inonotus obliquus) stimulates 3T3-L1 adipocyte differentiation https://www.ncbi.nlm.nih.gov/pubmed/21031614
  6. Chung et al (2010) Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells https://www.ncbi.nlm.nih.gov/pubmed/20607061
  7. Giridharan et al (2011) Amelioration of scopolamine induced cognitive dysfunction and oxidative stress by Inonotus obliquus - a medicinal mushroom https://www.ncbi.nlm.nih.gov/pubmed/21779570
  8. Lemieszek et al (2011) Anticancer effects of fraction isolated from fruiting bodies of Chaga medicinal mushroom, Inonotus obliquus (Pers.:Fr.) Pilát (Aphyllophoromycetideae): in vitro studies https://www.ncbi.nlm.nih.gov/pubmed/22135889
  9. Shibnev et al (2011) Antiviral activity of Inonotus obliquus fungus extract towards infection caused by hepatitis C virus in cell cultures https://www.ncbi.nlm.nih.gov/pubmed/22462058
  10. Yun et al (2011) Inonotus obliquus Protects against Oxidative Stress-Induced Apoptosis and Premature Senescence https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887607/
  11. Glamočlija et al (2015) Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal "mushroom" https://www.ncbi.nlm.nih.gov/pubmed/25576897
  12. Balandaykin et al (2015) Review on Chaga Medicinal Mushroom, Inonotus obliquus (Higher Basidiomycetes): Realm of Medicinal Applications and Approaches on Estimating its Resource Potential https://www.ncbi.nlm.nih.gov/pubmed/25746615
  13. Arata et al (2016) Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946216/
  14. Gery et al (2018) Chaga (Inonotus obliquus), a Future Potential Medicinal Fungus in Oncology? A Chemical Study and a Comparison of the Cytotoxicity Against Human Lung Adenocarcinoma Cells (A549) and Human Bronchial Epithelial Cells (BEAS-2B) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142110/


Type: Unknown Type




CUSTOMERS WHO BOUGHT THIS PRODUCT ALSO BOUGHT